Specialty pharmaceuticals company Mallinckrodt said it would buy pain drug maker Cadence Pharmaceuticals for about $1.3 billion to expand in the hospital market, where Cadence's products are widely used.
Mallinckrodt adds pain drug with $1.3 billion Cadence deal
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.